Stay updated on Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Sign up to get notified when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.

Latest updates to the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedFooter updates show Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed. The rest of the page content and study history remain unchanged.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry v3.3.2 is added to the history and the previous v3.3.1 entry is removed.SummaryDifference0.1%

- Check38 days agoChange DetectedThe latest history shows a new entry Revision: v3.3.1 added and Revision: v3.2.0 removed, reflecting a minor page revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange Detected- The banner about lapse in government funding and operating status updates has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedNew version entries appear in the Record History, adding updates to study status, recruitment status, and contacts/locations for the trial. These entries document ongoing changes to the trial record.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now communicates current operating status amid funding lapses and publicly states the new version v3.2.0, replacing the old v3.1.0.SummaryDifference10%

Stay in the know with updates to Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of PF-06650833, PF-06651600, and Tofacitinib in RA Clinical Trial page.